ARCHIVES

NCI Advisors Criticize Plan To Fund R01s On ESA Research With Amgen, J&J Money.

This article is from The Cancer Letter archive.

Vol. 34 No. 25 | June 27, 2008

Download PDF Visit The Full Archive

Related Articles

Scientific Program Organized For XIIIth Cancer Congress

October 2, 1981

Six-Year Follow Up Of Phase III Sprycel Trial Demonstrates 71 Percent Overall Survival

July 27, 2012

Nevins Retracts Key Paper By Duke Group, Raising Question Of Harm To Patients

October 29, 2010

House Appropriations by Institute

July 8, 1994

NCI, American Cancer Society Re-Evaluating Join Guidelines On Mammography Screening

September 17, 1993

NIH Says Its Probe Found Charges Of Double Payment “Basically Correct”

October 23, 1981